You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oligoprogression

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

Not yet recruiting
  • Ovarian Cancer Recurrent
  • Niraparib oral capsule
  • SBRT
  • Sutton, Surrey, United Kingdom
  • +1 more
Aug 10, 2023

NSCLC, EGFR Positive NSCLC, Oligoprogression Trial in München (Osimertinib, Radiotherapy)

Recruiting
  • NSCLC
  • +2 more
  • München, Germany
    LMU Klinikum der Universität München
May 17, 2022

NSCLC, Oligoprogressive Trial in Guangzhou (Furmonertinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Oligoprogressive
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 10, 2021

Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy Trial in Canada (Single fraction SABR, Multiple fraction

Not yet recruiting
  • Oligometastatic Disease
  • +3 more
  • Single fraction SABR
  • +3 more
  • Kelowna, British Columbia, Canada
  • +4 more
Mar 23, 2023

Brain Metastasis, Oligoprogression Trial in France (Hypofractionated SRT (stereotactic radiotherapy), Historical single-dose SRS

Active, not recruiting
  • Brain Metastasis
  • Oligoprogression
  • Hypofractionated SRT (stereotactic radiotherapy)
  • Historical single-dose SRS (stereotactic radiosurgery)
  • Bordeaux, France
  • +12 more
Aug 9, 2022

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer Trial in Montréal (Darolutamide (BAY1841788), SBRT)

Recruiting
  • Metastatic Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Darolutamide (BAY1841788)
  • SBRT
  • Montréal, Quebec, Canada
    Sir Mortimer JGH
Sep 20, 2021

Head Neck Cancer, Metastatic Cancer, Oligoprogressive Trial in Montréal (Standard arm, Experimental arm)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Standard arm
  • Experimental arm
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Mar 6, 2022

Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

Recruiting
  • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
  • Radiotherapy
  • +2 more
  • Rozzano, Milano, Italy
    Humanitas Research Hospital
May 3, 2022

NSCLC Trial (Cobicistat)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Feb 17, 2023

Proton SBRT and Immunotherapy for Recurrent/Progressive

Terminated
  • Head and Neck Cancer
  • Proton Stereotactic Body Radiation Therapy (SBRT) (5 fractions; 3500-4500 cGy)
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Aug 31, 2022

Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))

Active, not recruiting
  • Oligoprogressive Renal Cell Carcinoma
  • Stereotactic ablative body radiation (SABR)
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Nov 28, 2022

Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))

Recruiting
  • Oligoprogressive
  • Castration-Resistant Prostate Cancer
  • Stereotactic Body Radiation Therapy (SABR)
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Apr 9, 2021

Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)

Not yet recruiting
  • Breast Cancer Invasive
  • +2 more
  • Surgery
  • +2 more
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

Not yet recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Jun 23, 2022

Metastatic Tumors Trial in Prince George (Stereotactic Ablative Body Radiotherapy)

Active, not recruiting
  • Metastatic Tumors
  • Stereotactic Ablative Body Radiotherapy
  • Prince George, British Columbia, Canada
    BC Cancer
Apr 6, 2022

Oligometastatic Disease Trial in Milan (radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost,

Recruiting
  • Oligometastatic Disease
  • radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost, respectively
  • Milan, MI, Italy
    San Raffaele Scientific Institute
Dec 23, 2022

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • NSCLC Stage IV
  • EGFR Gene Mutation
  • Alessandria, Italy
  • +15 more
Mar 29, 2022

Metastatic Renal Cell Carcinoma, Radiotherapy Trial in France (Steretactic radiotherapy, Pursuit of ongoing systemic treatment)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Radiotherapy
  • Steretactic radiotherapy
  • Pursuit of ongoing systemic treatment
  • Albi, France
  • +17 more
Aug 9, 2022

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib , a combination group of SBRT, Lazertinib single administration group)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Lazertinib , a combination group of SBRT
  • Lazertinib single administration group
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 20, 2021

Lung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRT Trial in Shanghai (pemetrexed,cisplatin/carboplatin,bevacizumab,durvalumab,SBRT)

Not yet recruiting
  • Lung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRT
  • Shanghai, Shanghai, China
    Fudan University shanghai cancer center
Aug 16, 2020